Latest news with #CoA
Time Business News
6 days ago
- Business
- Time Business News
High-Quality RAD 140 for Sale – Tested & Proven
If you're searching for RAD 140 for Sale, you've likely heard about its potential for muscle growth and performance. PureRawz is a name that often comes up as a trusted source for this compound. RAD 140, also called Testolone, is a popular selective androgen receptor modulator (SARM) used in research for its ability to support muscle development and strength. This article explains what RAD 140 is, its benefits, how it's tested, and why quality matters when choosing a supplier. We'll keep things simple and clear so you can understand everything easily. RAD 140 is a type of SARM, a compound designed to target androgen receptors in the body. These receptors are found in muscles and bones, and when activated, they can help build muscle and improve strength. Unlike traditional steroids, RAD 140 is selective, meaning it focuses on specific tissues and aims to reduce unwanted side effects. It's mainly used for research purposes, as it's not approved for human consumption. Researchers are interested in RAD 140 because it shows promise in areas like muscle growth, fat loss, and even neuroprotection. Studies have explored its effects on animals, showing it can increase muscle mass and protect brain cells from damage. For example, one study found RAD 140 reduced cell death in rat neurons, which could have implications for diseases like Alzheimer's. When looking for RAD 140 for sale, quality is critical. Not all suppliers offer pure or safe products. Low-quality RAD 140 might not work as intended or could contain harmful impurities. High-quality RAD 140 should be: Third-Party Tested : This means an independent lab checks the product for purity and strength. Reputable suppliers like PureRawz provide Certificates of Analysis (CoA) to prove their products are clean and effective. : This means an independent lab checks the product for purity and strength. Reputable suppliers like PureRawz provide Certificates of Analysis (CoA) to prove their products are clean and effective. Pure : The product should be at least 98% pure to ensure it delivers the desired effects without contaminants. : The product should be at least 98% pure to ensure it delivers the desired effects without contaminants. Well-Packaged : Good packaging keeps the product safe and shows the supplier cares about quality. PureRawz, for instance, uses clean, sealed packaging with clear labeling. : Good packaging keeps the product safe and shows the supplier cares about quality. PureRawz, for instance, uses clean, sealed packaging with clear labeling. Backed by Reputation: Suppliers with a strong track record, like PureRawz, are trusted because they respond to customer questions and maintain high standards. Choosing a trusted supplier ensures you're getting a product that's safe for research and meets high standards. RAD 140 has caught attention for its potential benefits in research. Here's what studies and user experiences suggest: RAD 140 is known for helping build lean muscle. In animal studies, it increased body weight in young primates, showing strong anabolic effects. This makes it a popular choice for researchers studying muscle hypertrophy. Many users report noticeable muscle gains after a few weeks, especially when combined with exercise. One user shared that after nine weeks of RAD 140 at 20-30 mg daily, they saw enhanced lean muscle growth with a 'dry, grainy look.' Researchers have found RAD 140 can boost strength and stamina. In one case, a 64-year-old man reported cutting his bike commute time from 60 minutes to under 25 minutes after using RAD 140 for two months. This suggests it could help improve physical performance in research settings. RAD 140 may help burn fat while preserving muscle. Its ability to increase muscle mass can raise metabolism, which supports fat loss. This makes it appealing for studies on body composition. Beyond muscle, RAD 140 shows promise in protecting brain cells. In rat studies, it reduced cell death caused by harmful substances, suggesting potential benefits for brain health research. Compared to steroids, RAD 140 is designed to have fewer side effects. It targets muscles and bones without affecting other tissues, like the prostate. However, researchers must still follow safety guidelines, as long-term effects are not fully studied. Quality testing is a big deal when buying RAD 140. Reputable suppliers like PureRawz use third-party labs to verify their products. Here's how it works: Purity Testing : Labs check that the RAD 140 is at least 98% pure. This ensures it's free from harmful fillers or contaminants. : Labs check that the RAD 140 is at least 98% pure. This ensures it's free from harmful fillers or contaminants. Certificates of Analysis (CoA) : These documents show the exact composition of the product. Pure Rawz provides CoAs for transparency, so researchers know what they're getting. : These documents show the exact composition of the product. Pure Rawz provides CoAs for transparency, so researchers know what they're getting. Consistency: Each batch is tested to ensure it meets the same high standards every time. When buying RAD 140, always ask for proof of third-party testing. Suppliers like PureRawz make this easy by sharing lab reports on their website. PureRawz is a well-known name in the SARMs community, and for good reason. Here's why researchers choose them: Third-Party Testing : Every product, including RAD 140, is tested by independent labs. This builds trust and ensures quality. : Every product, including RAD 140, is tested by independent labs. This builds trust and ensures quality. Fast Shipping : Orders are fulfilled from the USA, so shipping is quick and reliable. Many users report receiving their orders in 3-15 days. : Orders are fulfilled from the USA, so shipping is quick and reliable. Many users report receiving their orders in 3-15 days. Wide Selection : PureRawz offers RAD 140 in various forms, like liquid, capsules, or stacks with other compounds like YK-11 or MK-677. This gives researchers flexibility. : PureRawz offers RAD 140 in various forms, like liquid, capsules, or stacks with other compounds like YK-11 or MK-677. This gives researchers flexibility. Customer Support : They're known for quick responses to questions, which is helpful for researchers with specific needs. : They're known for quick responses to questions, which is helpful for researchers with specific needs. Discounts: PureRawz often provides discount codes, like CAPRED25 for 15% off, making it more affordable to buy high-quality RAD 140. However, some users have reported slow shipping times, with delays up to 3.5 weeks. Despite this, the consensus is that PureRawz delivers legitimate, high-quality products. RAD 140 is typically studied in doses of 10-20 mg per day, though this can vary based on the research goals. Here are some tips for safe research: Start Low : Begin with a smaller dose, like 10 mg, to see how it affects the study subject. : Begin with a smaller dose, like 10 mg, to see how it affects the study subject. Cycle Properly : Researchers often use RAD 140 for 8-12 weeks, followed by a break to avoid potential tolerance buildup. : Researchers often use RAD 140 for 8-12 weeks, followed by a break to avoid potential tolerance buildup. Post-Cycle Therapy (PCT) : Some studies include PCT compounds, like Arimistane, to balance hormones after a cycle. PureRawz offers PCT products for this purpose. : Some studies include PCT compounds, like Arimistane, to balance hormones after a cycle. PureRawz offers PCT products for this purpose. Follow Guidelines: RAD 140 is for research only, not human consumption. Always follow local regulations and consult an Institutional Review Board (IRB) for clinical studies. When buying RAD 140, stick to trusted suppliers. PureRawz is a top choice due to its focus on quality and transparency. Other options include: Paradigm Peptides : Known for fast delivery and positive user reviews. One user reported great results with no side effects after using their RAD 140. : Known for fast delivery and positive user reviews. One user reported great results with no side effects after using their RAD 140. BehemothLabz : Offers lab-synthesized RAD 140 with third-party testing and fast shipping. : Offers lab-synthesized RAD 140 with third-party testing and fast shipping. Sports Technology Labs : Sells liquid RAD 140 with 98%+ purity, bottled in the USA. : Sells liquid RAD 140 with 98%+ purity, bottled in the USA. Chemyo: Praised for affordable powder options, though you'll need a precision scale for accurate dosing. Always check for third-party testing and read user reviews before buying. Avoid suppliers with poor customer service or no lab reports, as some Reddit users have warned about inconsistent experiences with certain vendors. While RAD 140 is promising, there are risks to consider: Not for Human Use : RAD 140 is sold for research only. It's not approved by the FDA or allowed by organizations like WADA. : RAD 140 is sold for research only. It's not approved by the FDA or allowed by organizations like WADA. Potential Side Effects : Though designed to minimize side effects, some researchers note temporary issues like fatigue or hormonal changes. Always monitor study subjects closely. : Though designed to minimize side effects, some researchers note temporary issues like fatigue or hormonal changes. Always monitor study subjects closely. Supplier Reliability : Some suppliers, including PureRawz, have faced complaints about slow shipping. Double-check stock availability before ordering. : Some suppliers, including PureRawz, have faced complaints about slow shipping. Double-check stock availability before ordering. Legal Issues: Ensure your research complies with local laws, as SARMs are regulated in many areas. Finding high-quality RAD 140 for Sale is easier when you choose a trusted supplier like PureRawz. With third-party testing, fast shipping, and a strong reputation, they're a go-to for researchers studying muscle growth, strength, and neuroprotection. RAD 140 offers exciting potential, but quality matters. Always verify purity, read user reviews, and follow research guidelines to ensure safe and effective studies. Whether you're exploring RAD 140 alone or in stacks, suppliers like PureRawz make it simple to get tested, proven products for your research needs. TIME BUSINESS NEWS
Al Etihad
15-07-2025
- Health
- Al Etihad
14-year-old Sudanese boy saved from congenital heart disease with minimally invasive surgery in Dubai
15 July 2025 18:47 A. SREENIVASA REDDY (ABU DHABI)A 14-year-old boy was treated at a UAE hospital for a rare congenital heart condition that had gone undetected since birth and could have proved fatal if left Muntassir, a Sudanese national, was brought to Aster Hospital Mankhool, Dubai, after experiencing persistent fatigue, a blackout episode, and elevated blood pressure — symptoms highly unusual for his age, a statement from the hospital initial cardiac assessment revealed signs of left ventricular hypertrophy, prompting advanced imaging, including ECG, echocardiogram, and CT aortography. These tests confirmed the presence of coarctation of the aorta (CoA), a congenital condition in which the aorta — the major artery carrying blood from the heart to the rest of the body — is abnormally is a relatively common congenital heart defect, accounting for about 4–6% of all such cases, and estimated to occur in roughly 1 out of every 2,900 live prenatal diagnosis is possible, it remains challenging, particularly in isolated cases. The condition is more prevalent in males.'While CoA is relatively common among congenital heart defects, diagnosis at adolescence — like in Mazin's case — is exceptionally rare,' the statement said.'This condition is most often detected in infancy or early childhood. It is extremely rare to diagnose coarctation of the aorta at the age of 14, as was the case with Mazin, making this a highly uncommon case' said doctors at Aster Hospital who treated was under the care of Dr. Naveed Ahmed, Head of Cardiology at Aster Hospitals & Clinics UAE and Consultant Interventional Cardiologist at Aster Hospital to about the case, Dr. Naveed said: 'CoA is typically diagnosed during infancy or early childhood. It's extremely rare to catch it this late, and had it gone unnoticed for a few more years, it could have led to permanent hypertension, heart failure, or even stroke.''While the procedure itself was technically smooth due to precise pre-procedural planning based on CT imaging, the true complexity of this case lies in the delayed diagnosis. Identifying and successfully treating the condition in adolescence after years of being missed made it both clinically challenging and unique,' he of open-heart surgery, the cardiology team opted for a minimally invasive coarctoplasty with stent placement, performed via the femoral artery. The outcome was excellent, and Mazin is expected to return to a full and active life.'The minimally invasive procedure involved the insertion of a balloon-mounted stent to open the narrowed section of the aorta. This approach avoids open surgery, reduces hospital stay, and ensures faster recovery — especially important for a young, active patient,' Dr. Naveed blood pressure normalised after the procedure, and he experienced a marked improvement in energy levels, resuming his daily activities within a day.'He is expected to return to sports and full physical activity within the next 4–6 weeks,' the doctor his heartfelt gratitude, Mazin said: 'Before the treatment, I felt tired all the time and couldn't play or do normal things like other kids. Now I feel healthy and strong again. I'm so grateful to Dr. Naveed and the team at Aster Hospital Mankhool for helping me get my life back.'His mother and brother, who accompanied him during treatment, also expressed deep appreciation toward Dr. Naveed and the entire medical and nursing staff for their care, compassion, and professionalism. Speaking to Aletihad , Dr. Naveed urged parents to be alert to potential signs of heart defects in children. 'When the child suffers recurrent chest infections, severe shortness of breath while playing with friends, and has frequent episodes of passing out, parents should take the child to a doctor for a detailed clinical examination and then to a cardiologist to confirm if he has any heart issues.' 'It is very important to detect congenital heart disease as early as possible and get it treated. Delay in diagnosis and treatment leads to permanent changes in the body and makes treatment difficult or impossible,' he added. On early detection, Dr. Naveed noted: 'Routine pre-natal ultrasound done during pregnancy to check for any congenital defects can sometimes detect heart defects, which later can be confirmed with fetal echocardiogram by a cardiologist.'
&w=3840&q=100)
First Post
14-07-2025
- Politics
- First Post
'Treaties are built on trust which can't flow with terror': Ex-diplomat on India's stand on Indus Waters Treaty
After India junked the Court of Arbitration's ruling on the Indus Waters Treaty, former diplomat Syed Akbaruddin said that treaties are built on trust and trust cannot flow with terrorism. He further said that India must link re-engagement to Pakistan's demonstrable action on terrorism. read more After India rejected The Hague-based Court of Arbitration's (CoA) ruling in the Indus Waters Treaty, former senior diplomat Syed Akbaruddin said that treaties are built on trust and trust cannot flow with terrorism. Last month, the CoA had ruled that it remained competent to arbitrate Pakistan's concerns over the Indus Waters Treaty despite India suspending the treaty. Pakistan had sought the CoA to arbitrate its concerns over India making two hydropower projects on the Indus River System prior to the treaty's suspension. STORY CONTINUES BELOW THIS AD Days after the Pahalgam attack in which terrorists killed 26 people, India on April 23 announced the suspension of the Indus Waters Treaty. India has said that the treaty would not be restored until Pakistan addresses terrorism-related concerns. In an article for The Indian Express, Akbaruddin said that while the CoA's ruling may be procedurally valid as it reflects the logic of legal permanence, the law cannot be blind to context and India did not put the treaty in abeyance lightly. 'It placed the Treaty in abeyance after Pakistan-based terrorists killed dozens of Indians in a brazen attack in Pahalgam on April 22. When blood stains the snow of the Pir Panjal, the abstractions of international law ring hollow. India has not cut off water or violated Pakistan's share. Instead, it has frozen the instruments of cooperation as a wake-up call. The message is stark: Treaties are built on trust, and trust cannot flow when terror does,' noted Akbaruddin, a former Permanent Representative of India to the United Nations. Akbaruddin also said that India must not re-engage with Pakistan on the Indus waters and other issues until there is evidence of action against terrorism. Akbaruddin said that 'India should craft a diplomatic path that links re-engagement to Pakistan's demonstrable action on terror'. 'This is not a compromise. It is conditional justice. If Pakistan wants the benefits of the Indus water system, it must stop using terror as a tool. India must also speak to the world with clarity. It is not undermining peace. It is demanding that peace be real. It is not holding water hostage. It is refusing to be hostage to hypocrisy,' noted Akbaruddin. At the same time, India must expand infrastructure to fully utilise both its entitled share of the eastern rivers and its permissible use of the western rivers under the Indus treaty under a transparent, precise, and speedy manner, noted Akbaruddin.
New Straits Times
14-07-2025
- Politics
- New Straits Times
Ex-judge loses appeal in RM100mil defamation suit against Sarawak Report editor
PUTRAJAYA: Former Sessions Court judge Mabel Sheela Muttiah has lost her appeal against a Kuala Lumpur High Court decision that dismissed her RM100 million defamation suit against Sarawak Report editor Clare Rewcastle Brown on a technicality. The technical grounds were Mabel's failure to translate two allegedly defamatory articles into Bahasa Melayu, a mandatory requirement for all pleadings filed in court in her suit over three articles. One of the article s was a 2015 Sarawak Report piece titled "How AG's office connived to prevent a second post-mortem on Kevin Morais — Exclusive Expose". A three-judge Court of Appeal (CoA) panel led by Datuk Azizah Nawawi today (July 14) dismissed Mabel's appeal, saying they were bound by another CoA ruling that a plaintiff must provide a Bahasa Malaysia text of an impugned defamatory article. "In this case, there was no Bahasa Malaysia translation of the impugned defamatory article, and that was clearly a non-compliance with Order 92 Rule 1 of the Rules of Court 2012. "We find there is no appealable error by the High Court. "The appeal is therefore dismissed with costs," she said. The court ordered Mabel to pay RM10,000 in costs to Rewcastle Brown. Azizah sat with judges Datuk Azizul Azmi Adnan and Datuk Ahmad Fairuz Zainol Abidin. Lawyers Guok Ngek Seong and Phyllia Lim acted for Rewcastle Brown while Mabel was represented by lawyers Datuk David Gurupatham and R. Venothani. Mabel was once a special officer to former attorney-general Tan Sri Mohamed Apandi Ali. In May last year, then High Court Judicial Commissioner (now judge) Datuk Raja Ahmad Mohzanuddin Shah Raja Mohzan said the requirement for complete pleadings in Bahasa Melayu is attributed to the language's supremacy as a national language. He said this was enshrined in Article 152 of the Federal Constitution and Section 8 of the National Language Act 1963/67 and Order 92 Rule 1 of the Rules of Court 2012. He said Mabel made an inference about the meaning of the articles and ruled that he would have awarded RM1 million in damages as one of the three articles was defamatory and injured her reputation, but there was still no certified translation in Bahasa Melayu.
Indian Express
11-07-2025
- Politics
- Indian Express
On Indus Waters Treaty, why India is right to boycott the ruling of Court of Arbitration
With the 'supplemental award' issued by the Court of Arbitration (CoA) on June 27, the spotlight is back on the Indus Waters Treaty (IWT). In the award, the CoA has held that it has 'a continuing responsibility to advance its proceedings in a timely, efficient, and fair manner without regard to India's position on 'abeyance', and that a failure to do so would be inconsistent with its obligations under the Treaty'. Interestingly, the CoA further held that the neutral expert is similarly competent to discharge its responsibilities, indicating that the IWT envisages overlapping jurisdiction concerning settlement of disputes as regards to the interpretation and application of the terms of IWT, despite a clear demarcation of jurisdiction under the IWT framework. This supplemental award has its roots in the Award on Competence dated July 6, 2023, whereby the CoA upheld its jurisdiction and competence to determine all aspects of the dispute set forth in the unilateral request for arbitration fronted by Pakistan in 2016. Through this request, Pakistan seeks to resolve issues concerning the design and operation of the hydro-electric plants (HEPs) on the Indus, Jhelum, and Chenab Rivers and their tributaries. The 2023 award was followed by a procedural order dated May 16, wherein the COA took cognisance of the statement issued by India's foreign secretary which indicated that 'the Indus Waters Treaty of 1960 will be held in abeyance with immediate effect, until Pakistan credibly and irrevocably abjures its support for cross-border terrorism'. Noting the development, the CoA requested each party to submit its response and its bearing on the competence of the CoA. Pakistan submitted its response on June 11, inter alia, alleging the weaponisation of water flowing from the Indus water system by India. The hearings proceeded ex-parte, with no submissions being advanced on behalf of India which is consistent with its earlier approach of boycotting any proceedings conducted by the CoA. Ultimately, the June 27 ruling was issued. This ruling sparked an immediate response by the Ministry of External Affairs, which emphatically rejected the ruling stating that an award rendered by an illegally constituted tribunal infringes the core aspects of the dispute resolution mechanism envisaged under the IWT, and is 'per se void'. Article IX(1) of the IWT places the onus of resolving any question concerning interpretation or application of the IWT or the existence of any fact which may establish a breach of the IWT, at the first instance, on the Permanent Indus Commission (PIC), constituted under Article VIII. The endeavour of the PIC is to resolve the said question mutually, failing which a 'difference' would be deemed to have arisen. Clause (2) of Article IX stipulates that a difference falling under Annexure F, Part I of the IWT must be dealt with by a highly-qualified engineer (termed as a 'neutral expert'). This provision is akin to a sole jurisdiction clause, which operates to the exclusion of all other modes of resolving differences. Differences relating to operations of any hydroelectric plant (HEP) constructed by India and its conformity with the provisions of the IWT fall under Part I of Annexure F, vesting exclusive jurisdiction in the neutral expert. The above interpretation of Article IX to the Treaty aligns with both Pakistan and India's position seeking appointment of a neutral expert for the resolution of the differences. However, such a request was withdrawn by Pakistan prior to filing its request for arbitration in 2016. Pertinently, a neutral expert has been appointed by the World Bank on October 13, 2022, and a decision on the neutral expert's competence was rendered on January 7 holding that the points of difference with respect to the aforestated HEPs fall within the scope of Part I of Annexure F. The hearing on merits is set to take place in accordance with the Revised Work Programme issued by the neutral expert on March 11, in which India is actively participating. In light of these developments, it is apparent that the CoA has been illegally constituted and has no competence or jurisdiction over the aforestated disputes. The findings of the CoA with respect to its competence stem from an incorrect reading of the provisions of the Treaty. According to the CoA, these provisions vest an overriding power in the Tribunal to decide whether it enjoys compétence de la compétence. However, the Tribunal has failed to note that the Treaty qualifies the competence of the CoA by subjecting it to other provisions of the IWT, including Article IX(2)(a) and (6) which vest broad and exclusive competence in the neutral expert to decide differences relating to design and operation of HEPs. Unless the neutral expert decides to refer the difference to arbitration, a CoA has no competence to look into the said issues. The Tribunal appreciates this aspect in a different section of its June 27 ruling where it quotes various provisions of the Treaty and observes that 'the primary source of law for this Court to interpret and apply is the Treaty'. Once this is made apparent, there is little room to squirm away from the exclusive mandate of the neutral expert to decide any and all issues pertaining to HEPs. Be that as it may, having established its continuing competence, the CoA is likely to furnish an award on merits. The question which logically follows is: What will be the status and effect of an award which is rendered by an illegally constituted CoA, particularly if it goes against the Indian standpoint? An award rendered by an international tribunal functioning under the aegis of the Permanent Court of Arbitration (a permanent arbitral body chosen as the Secretariat by the CoA) would fall under Article I(2) of the New York Convention (NYC) and acquire the characteristics of an 'arbitral award'. Consequently, it can be enforced under the NYC and all signatories to the NYC are obligated to recognise and enforce the award unless the embargos under Article V of the said convention come into play. Article V provides that recognition and enforcement of an arbitral award may be refused where, inter alia, it is shown that the said award contains decisions on matters beyond the scope of the submission to arbitration or the constitution of the arbitral tribunal was not in accordance with the agreement between the parties. The Indian Arbitration Act contains identical grounds for refusal of enforcement of a foreign award. Both these grounds will be available to the Indian state before its courts as and when and if the award on merits is sought to be enforced against it. The chances of these arguments succeeding are high. The source of all competence for any tribunal under any arbitral regime is the will of the parties including their consent to arbitrate, the extent of which is to be inferred from the text of the Treaty. Such competence is always subject to terms of the agreement which are birthed from the exercise of party autonomy. To circumvent the expression of such will by resorting to dubious means of interpretation simply to arrogate to itself competence which lies in the domain of another adjudicatory authority under the IWT violates the fundamentals on which international arbitration stands. The author is an Advocate-on-Record in the Supreme Court of India
